Virion Therapeutics is committed to developing treatments for cancer and chronic infections using targeted novel T cell-based immunotherapies that couple a checkpoint blockade with disease-specific antigenic stimulation.

Biotechnology

Virion

Virion's headquarters in Newark, DE, United States

Andrew D. Luber

Jacob P. Lalezari

Chirinjeev Kathuria

Sue Currie

Michael Paige

Neal Murakami

Michelle Berrey

Scott Strome

Thomas Penn

Joel Palefsky

Rafi Ahmed

Katherine A. High

Rifat Pamukcu

Bill Bradford

Steve Projan

Frank Borriello

The Scientific Research and Development team at Virion is dedicated to advancing innovative T cell-based immunotherapies for cancer and chronic infections. This multidisciplinary group, comprised of experts in chemistry, medical science, and strategic leadership, collaborates on the discovery and optimization of novel therapies that integrate checkpoint blockade with antigenic stimulation, driving both preclinical and clinical development efforts. Their work is pivotal in shaping the future of targeted immunotherapy and improving patient outcomes.

Scientific Research and Development

The Leadership Team at Virion Therapeutics is responsible for guiding the company's strategic vision and operational execution in the development of T cell-based immunotherapies for cancer and chronic infections. This diverse team, comprising the CEO, CFO, Chief Medical Officer, and other key executives, collaborates to ensure regulatory compliance, oversee clinical development, manage finances, and drive innovation in product manufacturing, ultimately working towards the successful delivery of novel therapies to patients.

Leadership Team

Virion

Org chart

Board & advisors

Teams

Scientific Research and Development

Leadership Team

Offices

Virion

Org chart

Board & advisors

Teams

Scientific Research and Development

Leadership Team

Offices

Related companies